[A CASE OF EOSINOPHILIC GASTROENTERITIS FOUND BY PICA DURING ORAL IMMUNOTHERAPY].


Journal

Arerugi = [Allergy]
ISSN: 0021-4884
Titre abrégé: Arerugi
Pays: Japan
ID NLM: 0241212

Informations de publication

Date de publication:
2020
Historique:
entrez: 20 3 2020
pubmed: 20 3 2020
medline: 3 4 2020
Statut: ppublish

Résumé

Eosinophilic esophagitis has been reported as a complication of oral immunotherapy (OIT), but there are only a few reports of eosinophilic gastroenteritis (EGE) occurring after OIT. EGE causes eosinophil infiltration into the gastrointestinal (GI) tract and is characterized by various digestive symptoms. We report the case of a 6-year-old boy with EGE. He was diagnosed as having immediate-type food allergies (egg, milk and wheat) by oral food challenges at 1 year of age. OIT for each food was carried out, and the amounts of the offending foods were able to be gradually increased without causing any immediate-type allergy symptoms. However, the total IgE and specific IgE values were remarkably increased at the age of 4 years and 4 months. He first developed oral mucosa symptoms and vomiting at 4 years and 10 months of age, and they gradually worsened. Stopping eggs and milk alleviated the symptoms. Nevertheless, he still occasionally vomited. He started Pica eating disorder (sand and sponge) due to anemia from 5 years and 10 months of age and developed eosinophilia without diarrhea or bloody stool. Upper and lower GI tract endoscopic examinations found no bleeding. The GI mucosa showed eosinophil infiltration of more than 40/high-power field in the stomach and duodenum, so he was diagnosed with EGE. No eosinophils were found in the esophageal mucosa. His GI symptoms and anemia improved on a multiple-food-elimination diet. Patients undergoing OIT should be closely followed up for a long time, and those with GI symptoms should be evaluated by GI endoscopy.

Identifiants

pubmed: 32188824
doi: 10.15036/arerugi.69.123
doi:

Types de publication

Case Reports Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

123-128

Auteurs

Koji Nishimura (K)

Allergy Center, National Center for Child Health and Development.

Tatsuki Fukuie (T)

Allergy Center, National Center for Child Health and Development.

Yumiko Miyaji (Y)

Allergy Center, National Center for Child Health and Development.

Yusuke Inuzuka (Y)

Allergy Center, National Center for Child Health and Development.

Kenji Toyokuni (K)

Allergy Center, National Center for Child Health and Development.

Makoto Irahara (M)

Allergy Center, National Center for Child Health and Development.

Fumi Ishikawa (F)

Allergy Center, National Center for Child Health and Development.

Miori Sato (M)

Allergy Center, National Center for Child Health and Development.

Mayako Saito (M)

Allergy Center, National Center for Child Health and Development.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development.

Masami Narita (M)

Allergy Center, National Center for Child Health and Development.

Ichiro Nomura (I)

Allergy Center, National Center for Child Health and Development.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH